September 19, 2025 Experience Oscar Health $410 million convertible senior subordinated notes and capped call transactions The 2.25% convertible notes are due 2030
September 19, 2025 Experience Norwegian Cruise Line Holdings comprehensive refinancing transactions The transactions included new debt, exchangeable debt, registered direct equity offerings and concurrent tender offers
September 18, 2025 Experience Bombardier $250 million senior notes offering The investment-grade senior notes are due 2033
September 18, 2025 Experience Natura sale of Avon International to Regent We are advising Natura on the sale
September 18, 2025 Experience Century Communities $500 million senior notes offering and concurrent redemption The high-yield notes are due 2033
September 17, 2025 Experience GrowthCurve Capital acquisition of PlanHub We advised GrowthCurve Capital on the transaction
September 17, 2025 Experience Royalty Pharma $2 billion senior notes offering We advised Royalty Pharma on its investment-grade notes offering
September 17, 2025 Experience Strive Nasdaq listing and $450 million at-the-market offering We advised Strive on its Nasdaq listing and offering
September 16, 2025 Experience Enovix $360 million convertible senior notes and capped call transactions The 4.75% convertible notes are due 2030
September 16, 2025 Experience Elevance Health $3 billion senior notes offering The investment-grade notes are due 2028, 2032, 2036 and 2055